Immuno oncology News and Research

RSS
Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Discovery could help develop a new treatment strategy for patients with melanoma

Discovery could help develop a new treatment strategy for patients with melanoma

Research provides insights on colorectal cancers’ immunotherapy resistance

Research provides insights on colorectal cancers’ immunotherapy resistance

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Peter Adams and Gerald Shadel receive NIH grant to explore the link between aging and liver cancer

Peter Adams and Gerald Shadel receive NIH grant to explore the link between aging and liver cancer

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Stem-like T cells within certain lymph nodes could be natural cancer fighters, study shows

Stem-like T cells within certain lymph nodes could be natural cancer fighters, study shows

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

Moffitt awarded $10.2 million grant to investigate lung cancer metabolism

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

Cmed Technology Adds More Capabilities to its Encapsia Platform and Reports Increased Demand for Use in Decentralized Trials (DCT)

A collaborative effort to evaluate treatment of liver and pancreatic tumors

A collaborative effort to evaluate treatment of liver and pancreatic tumors

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Dotmatics announces licensing agreement for informatics software with Compugen

Dotmatics announces licensing agreement for informatics software with Compugen

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma​

Taking Advantage of Measuring Molecular Collisional Cross-Sections in Pharma​

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients